Reinhard Haemmerle

Gene therapy for Wiskott-Aldrich syndrome-long - Term efficacy and genotoxicity (Science Translational Medicine)

D. Steinemann, A. Schambach, W. Al-Herz, 2014 .

Efficiency and Safety of O 6 -Methylguanine DNA Methyltransferase ( MGMT P140K )-Mediated In Vivo Selection in a Humanized Mouse Model

T. Moritz, U. Modlich, R. Phaltane, 2014 .

Efficiency and safety of O⁶-methylguanine DNA methyltransferase (MGMT(P140K))-mediated in vivo selection in a humanized mouse model.

T. Moritz, M. Rothe, U. Modlich, 2014, Human gene therapy.

Clonal Dominance With Retroviral Vector Insertions Near the ANGPT1 and ANGPT2 Genes in a Human Xenotransplant Mouse Model

A. Schambach, T. Moritz, M. Rothe, 2014, Molecular therapy. Nucleic acids.

Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

Michael Rothe, Christof von Kalle, Raffaele Fronza, 2014, Science Translational Medicine.

Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML.

Ulrich Lehmann, Ute Modlich, Michael Heuser, 2013, Blood.

Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.

D. Steinemann, D. Heckl, A. Schwarzer, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.